Theophylline
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72789-442 -
Package NDC
72789-442-01 -
Application number
ANDA215312 -
SPL ID
57c5cb6d-297f-7b7c-e063-6294a90a93a9 -
SPL set ID
5e64036a-ee3e-42e7-9e59-881f88a4e298 -
UNII
0I55128JYK -
RxCUI
314241
What the source publishes
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Active ingredients
- Theophylline
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Theophylline",
"splId": "57c5cb6d-297f-7b7c-e063-6294a90a93a9",
"labels": [
{
"setId": "5e64036a-ee3e-42e7-9e59-881f88a4e298",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e64036a-ee3e-42e7-9e59-881f88a4e298",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5e64036a-ee3e-42e7-9e59-881f88a4e298"
}
],
"routes": [
"ORAL"
],
"labeler": "PD-Rx Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-442-01)",
"package_ndc": "72789-442-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20241016"
}
],
"productId": "72789-442_57c5cb6d-297f-7b7c-e063-6294a90a93a9",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "72789-442",
"deaSchedule": null,
"genericName": "Theophylline",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "THEOPHYLLINE ANHYDROUS",
"strength": "450 mg/1"
}
],
"applicationNumber": "ANDA215312",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240927",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175790",
"M0023046"
],
"upc": [
"0372789442013"
],
"unii": [
"0I55128JYK"
],
"rxcui": [
"314241"
],
"spl_set_id": [
"5e64036a-ee3e-42e7-9e59-881f88a4e298"
],
"pharm_class_cs": [
"Xanthines [CS]"
],
"pharm_class_epc": [
"Methylxanthine [EPC]"
],
"manufacturer_name": [
"PD-Rx Pharmaceuticals, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72789-442_57c5cb6d-297f-7b7c-e063-6294a90a93a9"